Adding Calcitonin to Bupivacaine in Transversalis Fascia Plane Block for Cesarean Section
Not Applicable
Recruiting
- Conditions
- Transversalis Fascia Plane Block
- Registration Number
- NCT07033104
- Lead Sponsor
- Tanta University
- Brief Summary
Evaluate calcitonin as an adjuvant to bupivacaine in ultrasound guided tansversalis fascia plane block
- Detailed Description
Not available
Recruitment & Eligibility
- Status
- RECRUITING
- Sex
- Female
- Target Recruitment
- 70
Inclusion Criteria
- female pt ASA2 scheduled for cs under spinal anesthesia
Exclusion Criteria
- patient refusal ASAmore than 3 patients with pregnancy related disease emergency cs history of coagulopathy
Study & Design
- Study Type
- INTERVENTIONAL
- Study Design
- SEQUENTIAL
- Primary Outcome Measures
Name Time Method time to first rescue analgesia 24 hours
- Secondary Outcome Measures
Name Time Method
Related Research Topics
Explore scientific publications, clinical data analysis, treatment approaches, and expert-compiled information related to the mechanisms and outcomes of this trial. Click any topic for comprehensive research insights.
What molecular mechanisms underlie calcitonin's analgesic effects in transversalis fascia plane blocks?
How does calcitonin compare to other adjuvants like clonidine or epinephrine in enhancing bupivacaine analgesia for cesarean sections?
Are there specific biomarkers that predict enhanced analgesic response when calcitonin is added to bupivacaine in regional anesthesia?
What are the potential adverse events associated with calcitonin-bupivacaine combinations in obstetric anesthesia?
What other drugs or compounds have shown synergistic effects with bupivacaine in transversalis fascia plane blocks for pain management?
Trial Locations
- Locations (1)
tanta University hospital
🇪🇬Tanta, Gharbia, Egypt
tanta University hospital🇪🇬Tanta, Gharbia, Egypt